Terms: = Endocrine gland cancer AND MEN1, ENSG00000133895, 4221 AND Prognosis
119 results:
1. Updates on the genetics of multiple endocrine neoplasia.
Sahakian N; Castinetti F; Romanet P; Reznik Y; Brue T
Ann Endocrinol (Paris); 2024 Apr; 85(2):127-135. PubMed ID: 38325596
[TBL] [Abstract] [Full Text] [Related]
2. [Multiple neuroendocrine tumors of the pancreas].
Sipos B
Pathologie (Heidelb); 2024 Feb; 45(1):28-34. PubMed ID: 38180510
[TBL] [Abstract] [Full Text] [Related]
3. Management of Gastric Neuroendocrine Tumors: A Review.
Sok C; Ajay PS; Tsagkalidis V; Kooby DA; Shah MM
Ann Surg Oncol; 2024 Mar; 31(3):1509-1518. PubMed ID: 38062290
[TBL] [Abstract] [Full Text] [Related]
4. A review of functional pancreatic neuroendocrine tumors: Exploring the molecular pathogenesis, diagnosis and treatment.
Alshareefy Y; Cummins S; Mazzoleni A; Sharma V; Guggilapu S; Leong AWY; Wireko AA
Medicine (Baltimore); 2023 Nov; 102(46):e36094. PubMed ID: 37986400
[TBL] [Abstract] [Full Text] [Related]
5. [Predicting the presence of
Mokrysheva NG; Eremkina AK; Miliutina AP; Salimkhanov RK; Aboishava LA; Bibik EE; Gorbacheva AM; Elfimova AR; Kovaleva EV; Popov SV; Melnichenko GA
Probl Endokrinol (Mosk); 2023 Nov; 69(5):4-15. PubMed ID: 37968947
[TBL] [Abstract] [Full Text] [Related]
6. Immunohistochemical Glucagon-like Peptide-1 Receptor Expression in Human Insulinomas.
Vesterinen T; Peltola E; Leijon H; Hannula P; Huhtala H; Mäkinen MJ; Nieminen L; Pirinen E; Rönty M; Söderström M; Jaatinen P; Arola J
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894845
[TBL] [Abstract] [Full Text] [Related]
7. Multiple endocrine neoplasia type 1 with Zollinger-Ellison syndrome: clinicopathological analysis of a Japanese family with focus on menin immunohistochemistry.
Kimura N; Hirata Y; Iwashiro N; Kijima H; Takayasu S; Yamagata S; Sakihara S; Uchino S; Ohara M
Front Endocrinol (Lausanne); 2023; 14():1221514. PubMed ID: 37867522
[TBL] [Abstract] [Full Text] [Related]
8. Ultrasound-guided microwave ablation in the treatment of recurrent primary hyperparathyroidism in a patient with men1: a case report.
Liu Z; Zhao Y; Han X; Hu X; Zhang Y; Xu L; Chen G; Liu C; Xu S
Front Endocrinol (Lausanne); 2023; 14():1175377. PubMed ID: 37795364
[TBL] [Abstract] [Full Text] [Related]
9. Thymoma in multiple endocrine neoplasia type 1: a case report and systematic review.
Gao Y; Li R; Wu L; Yang H; Mao J; Zhao W
Endocrine; 2023 Nov; 82(2):442-449. PubMed ID: 37668926
[TBL] [Abstract] [Full Text] [Related]
10. Blood-based Proteomic Signatures Associated With men1-related Duodenopancreatic Neuroendocrine Tumor Progression.
Fahrmann JF; Wasylishen AR; Pieterman CRC; Irajizad E; Vykoukal J; Wu R; Dennison JB; Peterson CB; Zhao H; Do KA; Halperin DM; Agarwal SK; Blau JE; Jha S; Rivero JD; Nilubol N; Walter MF; Welch JM; Weinstein LS; Vriens MR; van Leeuwaarde RS; van Treijen MJC; Valk GD; Perrier ND; Hanash SM; Katayama H
J Clin Endocrinol Metab; 2023 Nov; 108(12):3260-3271. PubMed ID: 37307230
[TBL] [Abstract] [Full Text] [Related]
11. men1 Degradation Induced by Neddylation and the CUL4B-DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor Progression.
Xu J; Ye Z; Zhuo Q; Gao H; Qin Y; Lou X; Zhang W; Wang F; Wang Y; Jing D; Fan G; Zhang Y; Chen X; Chen J; Xu X; Yu X; Ji S
Cancer Res; 2023 Jul; 83(13):2226-2247. PubMed ID: 36939378
[TBL] [Abstract] [Full Text] [Related]
12. The Expression of Autophagy-Associated Genes Represents a Valid Footprint for Aggressive Pancreatic Neuroendocrine Neoplasms.
Matrood S; Melms LE; Bartsch DK; Di Fazio P
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835048
[TBL] [Abstract] [Full Text] [Related]
13. Aggressive versus indolent insulinomas: new clinicopathological insights.
Hackeng WM; Brosens LAA; Dreijerink KMA
Endocr Relat Cancer; 2023 May; 30(5):. PubMed ID: 36779771
[TBL] [Abstract] [Full Text] [Related]
14. Indications for genetic study in gastro-entero-pancreatic and thoracic neuroendocrine tumors.
Araujo-Castro M
Endocrinol Diabetes Nutr (Engl Ed); 2023 Mar; 70 Suppl 1():63-73. PubMed ID: 36396595
[TBL] [Abstract] [Full Text] [Related]
15. Analysis of 55 patients with multiple endocrine neoplasia type 1-associated insulinoma from a single center in China.
Zhao Y; Yu J; Liu Y; Lyu L; Ping F; Xu L; Li W; Wang O; Xu Q; Wu W; Zhang H; Li Y
Orphanet J Rare Dis; 2022 Jun; 17(1):219. PubMed ID: 35698198
[TBL] [Abstract] [Full Text] [Related]
16. Thymic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1.
Yliaska I; Tokola H; Ebeling T; Kuismin O; Ukkola O; Koivikko ML; Lesonen T; Rimpiläinen J; Felin T; Ryhänen E; Metso S; Schalin-Jäntti C; Salmela P
Endocrine; 2022 Sep; 77(3):527-537. PubMed ID: 35696052
[TBL] [Abstract] [Full Text] [Related]
17. Single-incision port robot-assisted surgery for thymic carcinoid tumor resection.
Shidei H; Mitsuboshi S; Yamamoto T; Kanzaki M
J Cardiothorac Surg; 2022 May; 17(1):90. PubMed ID: 35505364
[TBL] [Abstract] [Full Text] [Related]
18. [Comparison of clinical features between sporadic pancreatic neuroendocrine tumors and those associated with multiple endocrine neoplasia type 1].
Gu DY; Fu Q; Xue BY; Kan JB; Bai JA; Tang QY
Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(14):1014-1019. PubMed ID: 35399021
[No Abstract] [Full Text] [Related]
19. Update on the clinical management of multiple endocrine neoplasia type 1.
Pieterman CRC; Valk GD
Clin Endocrinol (Oxf); 2022 Oct; 97(4):409-423. PubMed ID: 35319130
[TBL] [Abstract] [Full Text] [Related]
20. Clinical implications of cell-of-origin epigenetic characteristics in non-functional pancreatic neuroendocrine tumors.
Dreijerink KM; Hackeng WM; Singhi AD; Heaphy CM; Brosens LA
J Pathol; 2022 Feb; 256(2):143-148. PubMed ID: 34750813
[TBL] [Abstract] [Full Text] [Related]
[Next]